Designed for the restorative general dentist, Biolase’s Waterlase C100 is said to provide clinical procedures including cavity preparation, early stage periodontal therapy and soft tissue procedures with more patient comfort compared to conventional instrumentation. First customer deliveries are expected to begin before the end of third quarter 2008.
According to the company, the Waterlase C100 all-tissue laser combines Waterlase yttrium scandium gallium garnet (YSGG) technology with excellent reliability, clinician control, operating efficiency, and flexibility in tip and accessory selection.
Waterlase C100 will be launched next week in Europe, as well as in other markets including Korea, Japan, Germany, Spain, Australia and New Zealand.
Jake Philip, CEO of Biolase, said: “Considering the broad range of clinical and cosmetic dental procedures made possible and more effective by our YSGG laser technology, offering a full range of products across the spectrum of price points should get us much closer to that goal.”